Changes in uric acid levels and estimated glomerular filtration rate slope after treatment with dotinurad in patients with hyperuricemia [0.03%]
治疗高尿酸血症患者后尿酸水平和肾小球滤过率斜率的变化
Tatsuya Mizoguchi,Kosuke Hayashi,Yoshiro Tsuruta et al.
Tatsuya Mizoguchi et al.
Urinary extracellular vesicles levels of n-3 and n-6 polyunsaturated fatty acids in children with steroid-sensitive nephrotic syndrome: a pilot study [0.03%]
儿童肾病综合征患者尿源性外泌体中n-3和n-6多不饱和脂肪酸水平：一项初步研究
Giulia Cricrì,William Morello,Stefano Turolo et al.
Giulia Cricrì et al.
Ultrasound-guided sharp recanalization for valve-related stenosis in the arteriovenous fistula: a single-center retrospective cohort study [0.03%]
超声引导下动静脉内瘘瓣膜狭窄锐性刨通术的单中心回顾性队列研究
Yi Hu,Heli Duan,Zonghui Zhang et al.
Yi Hu et al.
Objective: To compare the efficacy and safety of ultrasound-guided sharp recanalization (USR) with those of conventional percutaneous transluminal angioplasty (PTA) in the treatment of venous valve-related stenosis (VVRS)...
Changes in frailty and all-cause mortality in patients on hemodialysis: a prospective cohort study [0.03%]
一项前瞻性队列研究：透析患者的衰弱状况及全因死亡率的变化
Lan Liu,Jingjing Jin,Dongxue Zhang et al.
Lan Liu et al.
From glucosuria to dialysis: a case report of osmotic nephropathy due to an SGLT2 inhibitor [0.03%]
从尿糖到透析：一起由SGLT2抑制剂引起的渗透性肾病病例报告
Juan Castellanos-de la Hoz,Alejandra Molano-Triviño,Yesid Felipe González-García et al.
Juan Castellanos-de la Hoz et al.
Background: Osmotic nephropathy is an infrequent drug‑induced complication characterized by vacuolization of renal tubular cells secondary to lysosomal uptake, which increases osmotic pressure within the proximal tubule....
Potential biomarkers and regulatory pathways associated with arteriovenous fistula stenosis in end-stage renal disease: an analysis based on transcriptomic profiling [0.03%]
基于转录组学的终末期肾病动静脉瘘狭窄相关潜在生物标志物和调控通路研究分析
Ming Zhao,Yuxin An,Wanjun Li et al.
Ming Zhao et al.
C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report [0.03%]
利奴单抗和沙库巴曲/缬沙坦治疗C3突变相关的非典型溶血性尿毒症综合征合并严重肾功能不全及高血压危象的病例报告
Hiroki Yanagidani,Yujiro Maeoka,Maria Yoshida et al.
Hiroki Yanagidani et al.
FSTIV score is essential for clinical management and predicts outcome of idiopathic membranous nephropathy [0.03%]
FSTIV评分对特发性膜性肾病的临床管理和预后判断至关重要
Yonghua Liu,Mei Wang,Lirong Yang et al.
Yonghua Liu et al.
Predictive role of baseline serum creatinine-to-cystatin C ratio for renal dysfunction incidence in patients with acute ischemic stroke [0.03%]
基线血清肌酐-胱抑素C比值对急性缺血性卒中患者肾功能不全发生率预测作用的研究
Liyan Li,Yuesong Pan,Hongyi Yan et al.
Liyan Li et al.
Mesangial sclerosing glomerulopathy following luspatercept treatment - a case report [0.03%]
有关luspatercept治疗后发生系膜硬化性肾小球病的病例报告
Stanislas Bataille,Laurent Daniel,Julia Torrents et al.
Stanislas Bataille et al.
Luspatercept is a recombinant fusion protein that enhances late-stage erythropoiesis by inhibiting select transforming growth factor β (TGFβ) superfamily ligands. It is approved for transfusion-dependent β-thalassemia and myelodysplastic...